William Lis
2017 - Portola Pharmaceuticals
In 2017, William Lis earned a total compensation of $4.9M as Chief Executive Officer at Portola Pharmaceuticals, a 29% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $462,000 |
|---|---|
| Option Awards | $2,109,828 |
| Salary | $550,000 |
| Stock Awards | $1,755,875 |
| Other | $8,100 |
| Total | $4,885,803 |
Lis received $2.1M in option awards, accounting for 43% of the total pay in 2017.
Lis also received $462K in non-equity incentive plan, $550K in salary, $1.8M in stock awards and $8.1K in other compensation.
Rankings
In 2017, William Lis' compensation ranked 1,950th out of 14,666 executives tracked by ExecPay. In other words, Lis earned more than 86.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,950 out of 14,666 | 87th |
Division Manufacturing | 665 out of 5,770 | 89th |
Major group Chemicals And Allied Products | 176 out of 2,074 | 92nd |
Industry group Drugs | 131 out of 1,730 | 92nd |
Industry Pharmaceutical Preparations | 100 out of 1,329 | 93rd |
Source: SEC filing on April 24, 2018.
Lis' colleagues
We found four more compensation records of executives who worked with William Lis at Portola Pharmaceuticals in 2017.
2017
John Lawrence
Portola Pharmaceuticals
Chief Medical Officer
2017
Mardi Dier
Portola Pharmaceuticals
Chief Financial Officer
2017
Tao Fu
Portola Pharmaceuticals
Executive Vice President, Chief Commercial and Business Officer
2017
John Curnutte
Portola Pharmaceuticals